Events & Presentations – BeiGene SSE

Events & Presentations

Date Detail
Nov 20, 2024 Jefferies London Healthcare Conference on Wednesday, November 20th, 2024 at 2:30 pm GMT
Nov 12, 2024 Q3 2024 Earnings Materials
Sep 05, 2024 Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5th, 2024 at 10:00 am ET
Aug 07, 2024 Q2 2024 Earnings Materials
Jun 11, 2024 Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11th, 2024 at 1:20 pm ET
May 08, 2024 Q1 2024 Earnings Materials
Mar 11, 2024 Leerink Partners Global Biopharma Conference on Monday, March 11th, 2024 at 10:00 am ET
Mar 08, 2024 Investor Presentation - Q4 & FY 2023
Mar 05, 2024 TD Cowen 44th Annual Health Care Conference on Tuesday, March 5th, 2024 at 9:50 am ET
Feb 29 - Mar 03, 2024 International Congress on Hematologic Malignancies Poster Presentation from Thursday, February 29th thru Sunday, March 3rd: Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL): A Matching-Adjusted Indirect Comparison (MAIC)
Jan 08, 2024 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th, 2024 at 1:30 pm PST
Dec 10, 2023 BeiGene 2023 ASH Investor Event on Sunday, December 10th, 2023 at 8:00 pm PST
Nov 15, 2023 Jefferies London Healthcare Conference on Wednesday, November 15th, 2023 at 2:00 pm GMT
Sep 11, 2023 Morgan Stanley 21st Annual Global Healthcare Conference
Jul 18, 2023 BeiGene Investor Research and Development Day on Tuesday, July 18th, 2023 at 8:30am ET
June 12, 2023 Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12th, 2023 at 11:40 am ET
May 31, 2023 TD Cowen 4th Annual Oncology Innovation Summit on Wednesday, May 31st, 2023 at 12:00 pm ET
Mar 06, 2023 Cowen’s 43rd Annual Healthcare Conference on Monday, March 6th, 2023 at 11:10 am ET
Feb. 15, 2023 The SVB Securities Global Biopharma Conference
Feb. 08, 2023 The Guggenheim Oncology Conference 2023